Fluticasone Propionate Suppliers & Bulk Manufacturers
Available Forms: Inhalation suspension for use with nebulizers
Available Strengths: 0.5 mg/2 mL ampoules, 1 mg/2 mL ampoules
Reference Brands: Flixotide Nebules(EU)
Category:
Respiratory Disorder
Fluticasone Nebules (Flixotide) are corticosteroid inhalation suspensions used via nebulizer for asthma and respiratory inflammation. Available in the EU in 0.5 mg/2 mL and 1 mg/2 mL strengths, they offer effective maintenance therapy. Compounded versions are used off-label in the US. Ideal for B2B and export markets.
Fluticasone Propionate is available in Inhalation suspension for use with nebulizers
and strengths such as 0.5 mg/2 mL ampoules, 1 mg/2 mL ampoules.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Fluticasone Propionate is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Fluticasone Propionate can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Fluticasone Nebules (Fluticasone Propionate Inhalation Suspension) are a corticosteroid used in the long-term management of asthma and other chronic respiratory conditions. Available in the EU under the brand Flixotide Nebules, they come in 0.5 mg/2 mL and 1 mg/2 mL strengths and are administered via nebulizer for deep lung delivery. While not commonly sold as a branded product in the US, compounded versions are used off-label for similar indications. Fluticasone reduces airway inflammation, preventing symptoms and improving breathing. Ideal for Pharma B2B, PCD franchise, and export markets, especially where nebulizer therapy is preferred in pediatric and severe asthma cases.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing